Building healthier, resilient communities together

Beyond delivering innovative medicines and therapies, the research-based pharmaceutical industry is deeply committed to enhancing the health and lives of Filipinos, particularly those marginalized by poverty, geographic isolation, or disaster. This commitment is exemplified through the efforts of the Pharmaceutical and Healthcare Association of the Philippines (PHAP) and its social responsibility arm, the PHAP-Cares Foundation.

- TEODORO B. PADILLA

Established in 2003, PHAP-Cares has consistently provided support to communities in need, conducting medicine access initiatives, humanitarian missions, and health education campaigns. These programs are carried out in partnership with National Government agencies, local government units (LGUs), and civil society organizations — especially in areas affected by conflict, disease outbreaks, and natural calamities.

In a country that faces an average of 20 typhoons per year — eight or nine of which typically make landfall — the work of PHAPCares is both timely and critical. According to the Philippine Atmospheric, Geophysical and Astronomical Services Administration (PAGASA), the Philippines is the most typhoon-prone country in the world. These weather events often bring heavy rainfall, flooding, and destruction, leaving vulnerable populations with urgent needs for medical assistance and basic supplies.

In response, PHAPCares coordinates with member companies to mobilize resources and deliver aid where it’s most needed. One such company is Astellas Pharma Philippines, which actively supports PHAPCares’ mission through funding and collaboration.